Covidien (COV) Tops Q2 Views; Boosts Outlook
Tweet Send to a Friend
Covidien (NYSE: COV) reports Q2 earnings of $0.66 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
